CIK 0001469443 · Non-accelerated filer<br>Smaller reporting company
Arcadia Biosciences, Inc.
Sign in to watch- Ticker
- RKDA
- Exchange
- Nasdaq
- Industry
- Beverages
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810571538
- Phone
- 214-974-8921
- Business address
- 5956 SHERRY LANE, SUITE 2000, DALLAS, TX
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 64 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-10 | Yoder Amy Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 23,442 | ||
| 2026-09-10 | Comcowich Kevin Director | Grant or award · Stock Option (Right to Buy) | +23,000 | 54,042 | ||
| 2026-09-10 | WALLER GREGORY D Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 23,338 | ||
| 2026-09-10 | Murray Lilian Shackelford Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 23,287 | ||
| 2025-05-09 | Kawakami Mark Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +12,500 | 33,987 | ||
| 2025-05-09 | Schaefer Thomas J. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +12,500 | 37,975 | ||
| 2025-02-03 | Kawakami Mark Chief Financial Officer | Purchase | +700 | $2.49 | $2K | 2,681 |
| 2025-02-03 | Schaefer Thomas J. Chief Executive Officer | Purchase | +700 | $2.49 | $2K | 2,819 |
| 2024-08-19 | Yoder Amy Director | Grant or award · Stock Option (Right to Buy) | +10,909 | 13,442 | ||
| 2024-08-19 | WALLER GREGORY D Director | Grant or award · Stock Option (Right to Buy) | +10,909 | 13,338 | ||
| 2024-08-19 | Murray Lilian Shackelford Director | Grant or award · Stock Option (Right to Buy) | +10,909 | 13,287 | ||
| 2024-08-19 | Carosella Deborah D Director | Grant or award · Stock Option (Right to Buy) | +10,909 | 13,255 | ||
| 2024-08-19 | Bolles Albert D. Director | Grant or award · Stock Option (Right to Buy) | +10,909 | 13,394 | ||
| 2024-08-19 | Comcowich Kevin Director | Grant or award · Stock Option (Right to Buy) | +25,455 | 31,042 | ||
| 2024-08-19 | Kawakami Mark Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +20,000 | 21,487 | ||
| 2024-08-19 | Schaefer Thomas J. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +20,000 | 25,475 | ||
| 2024-08-01 | Kawakami Mark Chief Financial Officer | Purchase | +700 | $2.06 | $1K | 1,981 |
| 2024-08-01 | Schaefer Thomas J. Chief Executive Officer | Purchase | +700 | $2.06 | $1K | 2,119 |
| 2024-02-01 | Schaefer Thomas J. Chief Financial Officer | Purchase | +700 | $2.06 | $1K | 1,419 |
| 2023-08-04 | Schaefer Thomas J. Chief Financial Officer | Purchase | +649 | $3.67 | $2K | 719 |
Page 1 of 7 · 126 trades